HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
Taking everything into account, HIMS scores 6 out of 10 in our fundamental rating. HIMS was compared to 103 industry peers in the Health Care Providers & Services industry. HIMS has an excellent financial health rating, but there are some minor concerns on its profitability. HIMS is valued quite expensive, but it does show an excellent growth. These ratings would make HIMS suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
In the past year HIMS had a positive cash flow from operations.
In the past 5 years HIMS reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 18.44%, HIMS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Equity of HIMS (29.93%) is better than 95.15% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.93%, HIMS belongs to the top of the industry, outperforming 91.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROIC | 14.93% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 9.21%, HIMS belongs to the top of the industry, outperforming 93.20% of the companies in the same industry.
The Operating Margin of HIMS (6.48%) is better than 67.96% of its industry peers.
HIMS has a better Gross Margin (77.04%) than 91.26% of its industry peers.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HIMS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
HIMS has an Altman-Z score of 22.06. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HIMS (22.06) is better than 97.09% of its industry peers.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 22.06 |
ROIC/WACC1.66
WACC8.99%
2.3 Liquidity
A Current Ratio of 1.59 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS has a Current ratio (1.59) which is in line with its industry peers.
A Quick Ratio of 1.32 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS has a Quick ratio (1.32) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 7000.00%, which is quite impressive.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
The Revenue has grown by 85.99% in the past year. This is a very strong growth!
The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.96% yearly.
EPS Next Y26.77%
EPS Next 2Y33.96%
EPS Next 3Y33.61%
EPS Next 5Y41.75%
Revenue Next Year60.4%
Revenue Next 2Y38.65%
Revenue Next 3Y32.34%
Revenue Next 5Y24.96%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 69.41, the valuation of HIMS can be described as expensive.
HIMS's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.30. HIMS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 49.42 indicates a quite expensive valuation of HIMS.
The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.41 | ||
| Fwd PE | 49.42 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HIMS is more expensive than 62.14% of the companies in the same industry.
HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.32 | ||
| EV/EBITDA | 78.88 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 33.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.59
PEG (5Y)1.15
EPS Next 2Y33.96%
EPS Next 3Y33.61%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
47.89
-2.38 (-4.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.96%
Inst Owner Change0%
Ins Owners10.67%
Ins Owner Change12.05%
Market Cap10.72B
Analysts70
Price Target50.08 (4.57%)
Short Float %32.33%
Short Ratio1.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.39%
Min EPS beat(2)4.62%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)192.83%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)156.65%
EPS beat(12)11
Avg EPS beat(12)110.67%
EPS beat(16)12
Avg EPS beat(16)78.36%
Revenue beat(2)2
Avg Revenue beat(2)3.52%
Min Revenue beat(2)0.3%
Max Revenue beat(2)6.75%
Revenue beat(4)4
Avg Revenue beat(4)3.3%
Min Revenue beat(4)0.3%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.56%
Revenue beat(12)10
Avg Revenue beat(12)2.89%
Revenue beat(16)14
Avg Revenue beat(16)3.76%
PT rev (1m)15.17%
PT rev (3m)11.83%
EPS NQ rev (1m)4.69%
EPS NQ rev (3m)1.73%
EPS NY rev (1m)8.24%
EPS NY rev (3m)10.86%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-2.95%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.41 | ||
| Fwd PE | 49.42 | ||
| P/S | 6.01 | ||
| P/FCF | 45.32 | ||
| P/OCF | 32.06 | ||
| P/B | 19.52 | ||
| P/tB | 27.62 | ||
| EV/EBITDA | 78.88 |
EPS(TTM)0.69
EY1.44%
EPS(NY)0.97
Fwd EY2.02%
FCF(TTM)1.06
FCFY2.21%
OCF(TTM)1.49
OCFY3.12%
SpS7.97
BVpS2.45
TBVpS1.73
PEG (NY)2.59
PEG (5Y)1.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROCE | 18.9% | ||
| ROIC | 14.93% | ||
| ROICexc | 31.63% | ||
| ROICexgc | 71.61% | ||
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% | ||
| FCFM | 13.25% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 437.46% | ||
| Cap/Sales | 5.48% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 242.39% | ||
| Profit Quality | 143.86% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 22.06 |
F-Score6
WACC8.99%
ROIC/WACC1.66
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
EPS Next Y26.77%
EPS Next 2Y33.96%
EPS Next 3Y33.61%
EPS Next 5Y41.75%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
Revenue Next Year60.4%
Revenue Next 2Y38.65%
Revenue Next 3Y32.34%
Revenue Next 5Y24.96%
EBIT growth 1Y2214.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year366.35%
EBIT Next 3Y97.77%
EBIT Next 5Y66.66%
FCF growth 1Y3973.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14096.9%
OCF growth 3YN/A
OCF growth 5YN/A